| 800048 |
GYNECOLOGIC ONCOLOGY REPORTS |
Response to anti-DKK1 therapy in uterine carcinosarcoma: A case report |
2022-02-01 |
10.1016/j.gore.2021.100904 |
ElNaggar A., Zhang N., Scalise C.B., Sirard C., Kagey M.H., Vaena D., Arend R. |
| 800047 |
GYNECOLOGIC ONCOLOGY REPORTS |
High grade sarcoma with chondrosarcomatous differentiation in primary uterine leiomyosarcoma; A rare case and review of literature |
2022-02-01 |
10.1016/j.gore.2021.100905 |
Sadiq Qandeel, Khan Farhan |
| 800046 |
GYNECOLOGIC ONCOLOGY REPORTS |
Prevention of endometrial cancer through lifestyle Interventions: A systematic review and synthesis |
2022-02-01 |
10.1016/j.gore.2021.100900 |
Rundle-Thiele Dayle, Shrestha Sujal, Janda Monika |
| 800045 |
GYNECOLOGIC ONCOLOGY REPORTS |
Breast cancer risk in BRCA mutation carriers after diagnosis of epithelial ovarian cancer is lower than in carriers without ovarian cancer |
2022-02-01 |
10.1016/j.gore.2021.100899 |
Nañez Andrea, Stram Douglas A., Bethan Powell C., Garcia Christine |
| 800044 |
GYNECOLOGIC ONCOLOGY REPORTS |
Iliac Artery-Enteric Fistula Developed During Bevacizumab-Containing Chemotherapy for Recurrent Cervical Cancer: A Case Report and Literature Review |
2022-02-01 |
10.1016/j.gore.2022.100938 |
Karasawa Yuki, Mabuchi Seiji, Matsumoto Yuri, Umemoto Masahiko, Miyazaki Ayako, Watanabe Ayako, Okura Ryoko, Atsumi Risa, Sakurai Kosuke, Shibuya Takashi, Kitada Fuminori |
| 800043 |
GYNECOLOGIC ONCOLOGY REPORTS |
Increasing incidence of uterine carcinosarcoma: a United States Cancer Statistics study |
2022-02-01 |
10.1016/j.gore.2022.100936 |
Liao Cheng-I, Ann Caesar Michelle, Lee Danny, Chan Ava, Darcy Kathleen M, Tian Chunqiao, Kapp Daniel S, Chan John K |
| 800042 |
GYNECOLOGIC ONCOLOGY REPORTS |
Impressive and durable clinical responses obtained with dabrafenib and trametinib in low-grade serous ovarian cancer harbouring a BRAF V600E mutation |
2022-02-01 |
10.1016/j.gore.2022.100942 |
Lima Bárbara, Henriques Abreu Miguel, Sousa Susana, Bartosch Carla, Pereira Deolinda |
| 800041 |
GYNECOLOGIC ONCOLOGY REPORTS |
Re-treatment with PARPi in patients with recurrent epithelial ovarian cancer: a single institutional experience |
2022-02-01 |
10.1016/j.gore.2022.100939 |
Moubarak Malak, Harter Philipp, Ataseven Beyhan, Traut Alexander, Welz Julia, Baert Thais, Heitz Florian |
| 800040 |
GYNECOLOGIC ONCOLOGY REPORTS |
Assessment of wound perfusion with near-infrared angiography: a prospective feasibility study |
2022-02-01 |
10.1016/j.gore.2022.100940 |
Manning-Geist Beryl L., Cowan Renee A., Schlappe Brooke, Braxton Kenya, Sonoda Yukio, Long Roche Kara, Leitao Jr Mario M., Chi Dennis S., Zivanovic Oliver, Abu-Rustum Nadeem R., Mueller Jennifer J. |
| 800039 |
GYNECOLOGIC ONCOLOGY REPORTS |
Transcriptomic analysis of patient plasma reveals circulating miR200c as a potential biomarker for high-grade serous ovarian cancer |
2022-02-01 |
10.1016/j.gore.2021.100894 |
Hannan Natalie J, Cohen Paul A, Beard Sally, Bilic Sanela, Zhang Bonnie, Tong Stephen, Whitehead Clare, Hui Lisa |
